Results 51 to 60 of about 59,536 (251)
Oncocytic carcinoma of parotid gland
Of 0.5% all epithelial salivary gland malignancies are oncocytic cancers, a rare kind of parotid gland cancer. Clinical signs include discomfort and swelling in the cheek region, and the facial nerve is occasionally affected, leading to unilateral facial
Ho Xuan Tuan, MD, PhD +3 more
doaj +1 more source
Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A +4 more
core
MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas [PDF]
In view of the certain anatomic site-dependent frequency of chromosomal translocations involved in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) pathogenesis, 17 salivary gland MALT lymphoma cases were ...
Isaacson PG +8 more
core +1 more source
The petrotympanic canal (Huguier canal): Evolutionary, anatomical, and medical perspectives
Abstract The petrotympanic canal, traditionally referred to as Civinini's or Huguier's canal, represents an anatomical passage connecting the middle ear and temporomandibular joint (TMJ). Despite its early description, its structural complexity and functional significance have often been underestimated. In this study, we combined historical, anatomical,
Andrea Papini +8 more
wiley +1 more source
Diffuse Parotid Gland Enlargement Assosiated with Glycogen Storage Disease III: A Case Report
The purpose of this study was to explore the patient whose diffuse parotid gland enlargement propable related with glycogen storage disease III(Cori-Forbes Disease).
Ercan Akbay, Hatice Toy, Kayhan Öztürk
doaj +2 more sources
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
The management of benign parotid disease
Background Parotid gland tumor is the most common salivary gland tumors. Benign tumors account for about 80% of parotid gland tumors. However, due to the special anatomical location of the parotid gland and the different pathology of the tumor, there are
Rui Shi +4 more
doaj +1 more source
Accessory parotid gland tumors
Tumors of accessory parotid gland are considered in the differential diagnosis of a mid cheek mass. Parotidectomy is the procedure of choice. All pathological types of parotid main gland tumors occur in the accessory parotid gland also. Presenting as a mid cheek or infrazygomatic mass, the tumors of this accessory parotid gland are notorious for ...
Ramachar, Sreevathsa M. +1 more
openaire +3 more sources
Clock genes regulate Ca2+ signaling and mitochondrial bioenergetics to inhibit Sjogren's disease
Objective Although Ca2+ signaling and metabolism have been identified as key determinants for the development of Sjogren's disease (SjD), the intricate connection between them and salivary gland physiology remains poorly understood. Methods Fluorescence‐based Ca2+ imaging, RNA seq, and mitochondrial activity were used to investigate the effects of ...
Viktor R. Drel +12 more
wiley +1 more source
ORGAN-PRESERVING MICROSURGERY FOR PLEOMORPHIC ADENOMA OF THE PAROTID SALIVARY GLAND
Of the total number of salivary gland tumors, the parotid gland is affected by the tumoral process in 76.4–90% of cases. Among benign tumors of the parotid gland, the most frequent tumor (61.2–90%) is pleomorphic adenoma.
D.V. Steblovsky
doaj +1 more source

